Aulos Biosciences is now recruiting most cancers sufferers in Australian medical facilities for a trial of the world’s first antibody drug designed by a pc.
The computationally designed antibody, generally known as AU-007, was deliberate by the bogus intelligence platform of Israeli biotech firm Biolojic Design from Rehovot, in a means that may goal a protein within the human physique generally known as interleukin-2 (IL-2).